[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patients-who-undergo-pancreaticoduodenectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patients-who-undergo-pancreaticoduodenectomy":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100632511",false,"NCT07514637","Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg\u002FKgevery 8 Hours for Three Consecutive Days After Surgery.","The Safety and Efficacy of Aniracetamfen for Postoperative Analgesia and Rehabilitation After Pancreaticoduodenectomy: A Single-center, Single-arm Clinical Study","Inclusion Criteria:\n\n* Patients who underwent pancreatic surgery, including pancreaticoduodenectomy (PD), pancreatic-preserving pancreaticoduodenectomy (PPPD), and laparoscopic pancreaticoduodenectomy (LPD)\n* Age ≥ 18 years old and \\\u003C 80 years old\n* ASA Ⅰ-Ⅲ\n* Be able to clearly understand and voluntarily participate in the research\n\nExclusion Criteria:\n\n* Merging severe primary diseases involving the heart, brain, liver, kidneys and hematopoietic system\n* History of long-term use of psychotropic drugs and cognitive dysfunction\n* Having a history of acute poisoning from alcohol, sleeping pills, painkillers or other drugs that affect the central nervous system\n* Pregnancy or lactation period\n* History of allergy to NSAIDs, opioids, or to the test medication\n* Drug users, alcoholics, and opiate abusers\n* Those who had a history of chronic pain before the operation and a history of long-term use of analgesics and\u002For sedatives\n* Those who had thyroid dysfunction before the operation","ALL","18 Years","80 Years",{"count":19,"type":20},35,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","Exploring the effectiveness and safety of early use of Ariceptinfen after pancreaticoduodenectomy in alleviating postoperative pain and promoting recovery of patients.\n\nMain objective: To explore the analgesic effect of Anricfen after pancreaticoduodenectomy.\n\nSecondary objective: To explore the impact of Anricfen on the accelerated recovery after pancreaticoduodenectomy.\n\nExploratory objective: To investigate the biomarkers of Anricfen's analgesic effect after pancreaticoduodenectomy, as well as its correlation factors with tumor pathology.",[26],"Patients Who Undergo Pancreaticoduodenectomy",[28,29,30,31],"pancreaticoduodenectomy","Peripheral κ receptor agonist","analgesia","Promote recovery","RECRUITING","2026-04-01",{"date":35,"type":36},"2026-04-07","ACTUAL",{"date":38,"type":36},"2025-11-25",{"date":40,"type":20},"2026-03-31",{"name":42,"class":43},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","OTHER",""]